This comparison is arguably the most important in metabolic medicine heading into 2026, as it pits the two pharmaceutical giants against each other in the competition for the best-in-class obesity treatment
[DOI] [Google Scholar] 110.Hajem N., Chapelle A., Bignon J., Pinault A., Liu J.-M., Salah-Mohellibi N., Lati E., Wdzieczak-Bakala J
It's a cognitive stimulant for sure
(2018) reviewed BPC-157s vascular biology effects across multiple preclinical models, establishing the angiogenic component of this blend [2]
Synaptic proteins, neuropathology and cognitive status in the oldest-old
Independent of the species that triggers aggregation, it is generally accepted that a gain-of-function toxicity of the expanded ATXN3 protein contributes highly to SCA3 pathology